Sven Wehrwein insider trades

Open-market stock purchases and sales by Sven Wehrwein, Director at AtriCure, Inc, from SEC Form 4 filings since Feb 17, 2010.

Recent trades

DateStockTradeValue
Jul 28, 2026ATRC AtriCure, IncSold$946K
Jul 28, 2026ATRC AtriCure, IncBought (not open market)—
Jun 2, 2026PRLB Proto Labs IncSold$115K
Jun 2, 2026PRLB Proto Labs IncSold$39.2K
May 19, 2026PRLB Proto Labs IncBought (not open market)—
May 18, 2026ATRC AtriCure, IncBought (not open market)—
Nov 25, 2025ATRC AtriCure, IncSold$189K
Nov 25, 2025ATRC AtriCure, IncBought (not open market)—
Nov 24, 2025ATRC AtriCure, IncBought (not open market)—
Nov 24, 2025ATRC AtriCure, IncSold$188K

Companies traded

  • ATRC AtriCure, Inc: 6 sales, last Jul 28, 2026
  • PRLB Proto Labs Inc: 6 sales, last Jun 2, 2026
  • SPSC SPS Commerce Inc: 50 sales, last May 13, 2025
  • CGNT Cogentix Medical Inc /de/: other filings, last Jul 31, 2015
  • UPI Uroplasty Inc: 9 sales, last Mar 31, 2015
  • SYNO Synovis Life Technologies Inc: 13 sales, last Oct 26, 2011
  • VTAL Vital Images Inc: other filings, last Jun 15, 2011
  • ISNS Image Sensing Systems Inc: other filings, last May 25, 2011
  • CML Compellent Technologies Inc: 1 sale, last Feb 22, 2011

Get free alerts when Sven Wehrwein files a new trade →